Research and analysis

COVID-19 vaccine surveillance reports (weeks 19 to 38)

Data on the real-world effectiveness and impact of the COVID-19 vaccines.

From:
Public Health England
Published
14 May 2021
Last updated
23 September 2021 — See all updates

Documents

COVID-19 vaccine surveillance report: 23 September 2021 (week 38)

Ref: PHE publications gateway number: GOV-9885

PDF, 2.3 MB, 33 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

COVID-19 vaccine surveillance report: 16 September 2021 (week 37)

Ref: PHE gateway number GOV-9794

PDF, 1.29 MB, 33 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

COVID-19 vaccine surveillance report: 9 September 2021 (week 36)

Ref: PHE publications gateway number: GOV-9692

PDF, 1.21 MB, 33 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

COVID-19 vaccine surveillance report: 2 September 2021 (week 35)

Ref: PHE gateway number GOV-9606

PDF, 1.23 MB, 25 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

COVID-19 vaccine surveillance report: 26 August 2021 (week 34)

PDF, 1.6 MB, 24 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

COVID-19 vaccine surveillance report: 19 August 2021 (week 33)

Ref: PHE gateway number GOV-9429

PDF, 1.16 MB, 24 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

COVID-19 vaccine surveillance report: 12 August 2021 (week 32)

Ref: PHE publications gateway number: GOV-9343

PDF, 2.07 MB, 24 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

COVID-19 vaccine surveillance report: 5 August 2021 (week 31)

Ref: PHE gateway number GOV-9268

PDF, 3.78 MB, 24 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

COVID-19 vaccine surveillance report: 29 July 2021 (week 30)

Ref: PHE publications gateway number: GOV-9196

PDF, 1.88 MB, 24 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

COVID-19 vaccine surveillance report: 22 July 2021 (week 29)

Ref: PHE gateway number: GOV-9112

PDF, 972 KB, 24 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

COVID-19 vaccine surveillance report: 15 July 2021 (week 28)

Ref: PHE gateway number GOV-9000

PDF, 1.15 MB, 24 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

COVID-19 vaccine surveillance report: 8 July 2021 (week 27)

Ref: PHE gateway number GOV-8931

PDF, 1.23 MB, 25 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

COVID-19 vaccine surveillance report: 1 July 2021 (week 26)

Ref: PHE gateway number GOV-8845

PDF, 893 KB, 28 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

COVID-19 vaccine surveillance report: 24 June 2021 (week 25)

Ref: PHE gateway number GOV-8765

PDF, 895 KB, 22 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

COVID-19 vaccine surveillance report: 17 June 2021 (week 24)

Ref: PHE gateway number GOV-8694

PDF, 917 KB, 22 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

COVID-19 vaccine surveillance report: 10 June 2021 (week 23)

Ref: PHE publications gateway number: GOV-8620

PDF, 1.1 MB, 22 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

COVID-19 vaccine surveillance report: 3 June 2021 (week 22)

Ref: PHE publications gateway number: GOV-8544

PDF, 860 KB, 23 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

COVID-19 vaccine surveillance report: 27 May 2021 (week 21)

Ref: PHE gateway number GOV-8481

PDF, 1.11 MB, 21 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

COVID-19 vaccine surveillance report: 20 May 2021 (week 20)

Ref: PHE gateway number GOV-8401

PDF, 985 KB, 22 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

COVID-19 vaccine surveillance report: 13 May 2021 (week 19)

Ref: PHE gateway number GOV-8305

PDF, 4.08 MB, 19 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Since the beginning of the programme, Public Health England (PHE) has been monitoring the effectiveness of the vaccines in the real world as set out in the COVID-19 vaccine surveillance strategy and the impact on:

  • symptomatic disease
  • hospitalisation
  • death
  • infection (symptomatic or asymptomatic)
  • transmission

Further reports on monitoring of the effectiveness of COVID-19 vaccination have been published.

Reports from week 39 are available and reports prior to week 19 are available as part of the National flu and COVID-19 surveillance reports.

Updates to this page

Published 14 May 2021
Last updated 23 September 2021 + show all updates

  1. Added week 38 report.

  2. Updated formatting of Table 3 in week 37 report.

  3. Added COVID-19 vaccine surveillance report: 16 September 2021 (week 37).

  4. Updated Table 6 and Figure 2(d) in week 36 report.

  5. Added COVID-19 vaccine surveillance report: 9 September 2021 (week 36).

  6. Added COVID-19 vaccine surveillance report: 2 September 2021 (week 35).

  7. Added COVID-19 vaccine surveillance report: 26 August 2021 (week 34).

  8. Added week 33 report: vaccine coverage updated.

  9. Added COVID-19 vaccine surveillance report: 19 August 2021 (week 33).

  10. Added COVID-19 vaccine surveillance report: 12 August 2021 (week 32).

  11. Added COVID-19 vaccine surveillance report: 5 August 2021 (week 31).

  12. Added week 30 report.

  13. Added COVID-19 vaccine surveillance report: 22 July 2021 (week 29).

  14. Added COVID-19 vaccine surveillance report: 15 July 2021 (week 28).

  15. Added COVID-19 vaccine surveillance report: 8 July 2021 (week 27).

  16. Added COVID-19 vaccine surveillance report: 1 July 2021 (week 26).

  17. Added latest weekly report.

  18. Updated figure 1a in the COVID-19 vaccine surveillance report: 17 June 2021 (week 24).

  19. Added COVID-19 vaccine surveillance report: 17 June 2021 (week 24).

  20. Added COVID-19 vaccine surveillance report: 10 June 2021 (week 23).

  21. Added COVID-19 vaccine surveillance report: 3 June 2021 (week 22).

  22. Added COVID-19 vaccine surveillance report: 27 May 2021 (week 21).

  23. Added COVID-19 vaccine surveillance report: 20 May 2021 (week 20).

  24. First published.

Sign up for emails or print this page

Related content